Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Titel:
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Auteur:
Redfield, Robert R. Jordan, Stanley C. Busque, Stephan Vincenti, Flavio Woodle, E. Steve Desai, Niraj Reed, Elaine F. Tremblay, Simon Zachary, Andrea A. Vo, Ashley A. Formica, Richard Schindler, Thomas Tran, Ha Looney, Caroline Jamois, Candice Green, Cherie Morimoto, Alyssa Rajwanshi, Richa Schroeder, Aaron Cascino, Matthew D. Brunetta, Paul Borie, Dominic
Verschenen in:
American journal of transplantation
Paginering:
Jaargang 19 () nr. 11 pagina's 3035-3045
Jaar:
2019
Inhoud:
Uitgever:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.